• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安慰剂性痛觉过敏中的学习机制:条件作用与消退过程的作用。

Learning mechanisms in nocebo hyperalgesia: the role of conditioning and extinction processes.

作者信息

Thomaidou Mia Athina, Veldhuijzen Dieuwke Swaantje, Peerdeman Kaya Joanne, Wiebing Naomi Zoë Sifra, Blythe Joseph Sullivan, Evers Andrea Walbruga Maria

机构信息

Health, Medical and Neuropsychology Unit, Leiden University, Leiden, the Netherlands.

Leiden Institute for Brain & Cognition, Leiden, the Netherlands.

出版信息

Pain. 2020 Jul;161(7):1597-1608. doi: 10.1097/j.pain.0000000000001861.

DOI:10.1097/j.pain.0000000000001861
PMID:32149863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7302337/
Abstract

Nocebo hyperalgesia is a clinically relevant phenomenon and may be formed as a result of associative learning, implemented by classical conditioning. This study explored for the first time distinct nocebo conditioning methods and their consequences for nocebo attenuation methods. Healthy participants (N = 140) were recruited and randomized to the following nocebo hyperalgesia induction groups: conditioning with continuous reinforcement (CRF), conditioning with partial reinforcement (PRF), and a sham-conditioning control group. In the attenuation phase, counterconditioning was compared with extinction. During induction, participants experienced increased thermal pain in 100% of nocebo trials in the CRF groups, while in only 70% of nocebo trials in the PRF groups. During evocation, pain stimulation was equivalent across all trials. During attenuation, pain stimulation was decreased on nocebo trials relative to control trials for the counterconditioning groups, while pain remained equivalent across all trials for the extinction groups. Results showed that both PRF and CRF significantly induced nocebo hyperalgesia, but CRF was a more potent nocebo induction method, as compared to PRF. Counterconditioning was more effective than extinction in attenuating nocebo hyperalgesia. Neither CRF nor PRF resulted in resistance to extinction. However, compared with CRF, conditioning with PRF resulted in more resistance to counterconditioning. These findings demonstrate that the more ambiguous learning method of PRF can induce nocebo hyperalgesia and may potentially explain the treatment resistance and chronification seen in clinical practice. Further research is required to establish whether attenuation with counterconditioning is generalizable to clinical settings.

摘要

安慰剂性痛觉过敏是一种具有临床相关性的现象,可能是由经典条件作用所实现的联想学习形成的。本研究首次探索了不同的安慰剂性条件作用方法及其对安慰剂性痛觉过敏缓解方法的影响。招募了健康参与者(N = 140)并将其随机分为以下安慰剂性痛觉过敏诱导组:连续强化条件作用(CRF)组、部分强化条件作用(PRF)组和假条件作用对照组。在缓解阶段,将对抗条件作用与消退进行比较。在诱导阶段,CRF组100%的安慰剂试验中参与者的热痛增加,而PRF组仅70%的安慰剂试验中出现这种情况。在激发阶段,所有试验中的疼痛刺激是等效的。在缓解阶段,对抗条件作用组的安慰剂试验中疼痛刺激相对于对照试验有所降低,而消退组所有试验中的疼痛保持等效。结果表明,PRF和CRF均显著诱导了安慰剂性痛觉过敏,但与PRF相比,CRF是一种更强效的安慰剂诱导方法。在减轻安慰剂性痛觉过敏方面,对抗条件作用比消退更有效。CRF和PRF均未导致对消退的抵抗。然而,与CRF相比,PRF条件作用导致对对抗条件作用的抵抗更强。这些发现表明,PRF这种更模糊的学习方法可诱导安慰剂性痛觉过敏,并可能潜在地解释临床实践中所见的治疗抵抗和慢性化现象。需要进一步研究以确定对抗条件作用的缓解方法是否可推广到临床环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/4fe06067c760/jop-161-1597-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/540c20ee73e4/jop-161-1597-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/06b6d2b27372/jop-161-1597-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/39cdeab289fe/jop-161-1597-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/5438391cf73c/jop-161-1597-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/d95adf55ce22/jop-161-1597-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/4fe06067c760/jop-161-1597-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/540c20ee73e4/jop-161-1597-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/06b6d2b27372/jop-161-1597-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/39cdeab289fe/jop-161-1597-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/5438391cf73c/jop-161-1597-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/d95adf55ce22/jop-161-1597-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09da/7302337/4fe06067c760/jop-161-1597-g008.jpg

相似文献

1
Learning mechanisms in nocebo hyperalgesia: the role of conditioning and extinction processes.安慰剂性痛觉过敏中的学习机制:条件作用与消退过程的作用。
Pain. 2020 Jul;161(7):1597-1608. doi: 10.1097/j.pain.0000000000001861.
2
Nocebo Hyperalgesia, Partial Reinforcement, and Extinction.反安慰剂痛觉过敏、部分强化和消退。
J Pain. 2015 Oct;16(10):995-1004. doi: 10.1016/j.jpain.2015.06.012. Epub 2015 Jul 11.
3
Efficacy of open-label counterconditioning for reducing nocebo effects on pressure pain.开放性反条件作用减轻压痛中安慰剂效应的疗效。
Eur J Pain. 2023 Aug;27(7):831-847. doi: 10.1002/ejp.2112. Epub 2023 Apr 3.
4
Susceptibility to Nocebo Hyperalgesia, Dispositional Optimism, and Trait Anxiety as Predictors of Nocebo Hyperalgesia Reduction.易患非安慰剂性痛觉过敏、性格乐观和特质焦虑作为预测非安慰剂性痛觉过敏减轻的指标。
Clin J Pain. 2023 Jun 1;39(6):259-269. doi: 10.1097/AJP.0000000000001112.
5
Nocebo Hyperalgesia in Patients With Fibromyalgia and Healthy Controls: An Experimental Investigation of Conditioning and Extinction Processes at Baseline and 1-Month Follow-up.纤维肌痛患者和健康对照者的非安慰剂性痛觉过敏:基线和 1 个月随访时条件反射和消退过程的实验研究。
J Pain. 2023 Sep;24(9):1696-1711. doi: 10.1016/j.jpain.2023.05.003. Epub 2023 May 23.
6
Effects of Oxytocin on Placebo and Nocebo Effects in a Pain Conditioning Paradigm: A Randomized Controlled Trial.催产素对疼痛条件反射范式中安慰剂和反安慰剂效应的影响:一项随机对照试验。
J Pain. 2020 Mar-Apr;21(3-4):430-439. doi: 10.1016/j.jpain.2019.08.010. Epub 2019 Sep 5.
7
An experimental investigation into the mediating role of pain-related fear in boosting nocebo hyperalgesia.关于疼痛相关恐惧在增强安慰剂性痛觉过敏中中介作用的实验研究。
Pain. 2021 Jan;162(1):287-299. doi: 10.1097/j.pain.0000000000002017.
8
Autonomic Arousal as a Mechanism of the Persistence of Nocebo Hyperalgesia.自主唤醒作为非安慰剂性痛觉过敏持续存在的机制。
J Pain. 2018 May;19(5):476-486. doi: 10.1016/j.jpain.2017.12.006. Epub 2017 Dec 18.
9
Nocebo hyperalgesia can be induced by classical conditioning without involvement of expectancy.非安慰剂性痛觉过敏可通过经典条件作用而产生,而无需涉及期望。
PLoS One. 2020 May 7;15(5):e0232108. doi: 10.1371/journal.pone.0232108. eCollection 2020.
10
Partial reinforcement, extinction, and placebo analgesia.部分强化、消退和安慰剂镇痛。
Pain. 2014 Jun;155(6):1110-1117. doi: 10.1016/j.pain.2014.02.022. Epub 2014 Mar 3.

引用本文的文献

1
Electrophysiological markers for anticipatory processing of nocebo-augmented pain.对安慰剂增强疼痛的预期处理的电生理标志物。
PLoS One. 2023 Jul 26;18(7):e0288968. doi: 10.1371/journal.pone.0288968. eCollection 2023.
2
Placebo and nocebo effects: from observation to harnessing and clinical application.安慰剂和反安慰剂效应:从观察到利用及临床应用
Transl Psychiatry. 2022 Dec 24;12(1):524. doi: 10.1038/s41398-022-02293-2.
3
A randomized pharmacological fMRI trial investigating D-cycloserine and brain plasticity mechanisms in learned pain responses.

本文引用的文献

1
How to prevent, minimize, or extinguish nocebo effects in pain: a narrative review on mechanisms, predictors, and interventions.如何预防、减轻或消除疼痛中的反安慰剂效应:关于机制、预测因素和干预措施的叙述性综述
Pain Rep. 2019 Jun 7;4(3):e699. doi: 10.1097/PR9.0000000000000699. eCollection 2019 May-Jun.
2
To Experience or to Be Informed? Classical Conditioning Induces Nocebo Hyperalgesia even when Placebo Analgesia Is Verbally Suggested-Results of a Preliminary Study.体验还是知情?即使在口头暗示安慰剂镇痛的情况下,经典条件反射也会引起伤害性感受过敏——一项初步研究的结果。
Pain Med. 2020 Mar 1;21(3):548-560. doi: 10.1093/pm/pnz123.
3
一项随机药理学 fMRI 试验,研究 D-环丝氨酸和学习性疼痛反应中的大脑可塑性机制。
Sci Rep. 2022 Nov 9;12(1):19080. doi: 10.1038/s41598-022-23769-7.
4
Counterconditioning as Treatment to Reduce Nocebo Effects in Persistent Physical Symptoms: Treatment Protocol and Study Design.对抗条件作用作为减轻持续性身体症状中反安慰剂效应的治疗方法:治疗方案与研究设计
Front Psychol. 2022 Jun 13;13:806409. doi: 10.3389/fpsyg.2022.806409. eCollection 2022.
5
Induction and generalization of nocebo effects on itch.安慰剂反效应对瘙痒的诱导与概括
Exp Dermatol. 2022 Jun;31(6):878-889. doi: 10.1111/exd.14522. Epub 2022 Feb 6.
Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus.
安慰剂和反安慰剂效应对临床实践的影响:专家共识。
Psychother Psychosom. 2018;87(4):204-210. doi: 10.1159/000490354. Epub 2018 Jun 12.
4
Differential Classical Conditioning of the Nocebo Effect: Increasing Heat-Pain Perception without Verbal Suggestions.无安慰剂效应的差异经典条件作用:在无言语暗示的情况下增强热痛感知。
Front Psychol. 2017 Dec 13;8:2163. doi: 10.3389/fpsyg.2017.02163. eCollection 2017.
5
Autonomic Arousal as a Mechanism of the Persistence of Nocebo Hyperalgesia.自主唤醒作为非安慰剂性痛觉过敏持续存在的机制。
J Pain. 2018 May;19(5):476-486. doi: 10.1016/j.jpain.2017.12.006. Epub 2017 Dec 18.
6
Minimizing nocebo effects by conditioning with verbal suggestion: A randomized clinical trial in healthy humans.通过言语暗示进行条件作用以最小化反安慰剂效应:一项针对健康人的随机临床试验。
PLoS One. 2017 Sep 14;12(9):e0182959. doi: 10.1371/journal.pone.0182959. eCollection 2017.
7
Classical conditioning without verbal suggestions elicits placebo analgesia and nocebo hyperalgesia.没有言语暗示的经典条件作用会引发安慰剂镇痛和反安慰剂痛觉过敏。
PLoS One. 2017 Jul 27;12(7):e0181856. doi: 10.1371/journal.pone.0181856. eCollection 2017.
8
The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment Outcomes.安慰剂和反安慰剂现象:它们的临床管理及其对治疗结果的影响。
Clin Ther. 2017 Mar;39(3):477-486. doi: 10.1016/j.clinthera.2017.01.031. Epub 2017 Feb 23.
9
Psychological Placebo and Nocebo Effects on Pain Rely on Expectation and Previous Experience.心理安慰剂和反安慰剂效应在疼痛方面依赖于期望和既往经历。
J Pain. 2016 Feb;17(2):203-14. doi: 10.1016/j.jpain.2015.10.010. Epub 2015 Oct 31.
10
Fear of pain potentiates nocebo hyperalgesia.对疼痛的恐惧会增强安慰剂性痛觉过敏。
J Pain Res. 2015 Oct 12;8:703-10. doi: 10.2147/JPR.S91923. eCollection 2015.